Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.

Lee H, Kim H, Lee G, Chung HS, Bae H.

Br J Nutr. 2013 Jul 14;110(1):69-76. doi: 10.1017/S0007114512004734. Epub 2012 Nov 27.

PMID:
23181951
2.

Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.

Lui SL, Yung S, Tsang R, Zhang F, Chan KW, Tam S, Chan TM.

Lupus. 2008 Apr;17(4):305-13. doi: 10.1177/0961203307088289.

PMID:
18413412
3.

Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.

Werwitzke S, Trick D, Kamino K, Matthias T, Kniesch K, Schlegelberger B, Schmidt RE, Witte T.

Arthritis Rheum. 2005 Nov;52(11):3629-38.

4.

Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF/BLyS production.

Postól E, Meyer A, Cardillo F, de Alencar R, Pessina D, Nihei J, Mariano M, Mengel J.

Immunology. 2008 Oct;125(2):184-96. doi: 10.1111/j.1365-2567.2008.02835.x. Epub 2008 Apr 7.

5.

Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.

Youd M, Blickarz C, Woodworth L, Touzjian T, Edling A, Tedstone J, Ruzek M, Tubo R, Kaplan J, Lodie T.

Clin Exp Immunol. 2010 Jul 1;161(1):176-86. doi: 10.1111/j.1365-2249.2010.04158.x. Epub 2010 Apr 29.

6.

CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.

Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.

Arthritis Rheum. 2012 Apr;64(4):1237-46. doi: 10.1002/art.33424. Epub 2011 Oct 17.

7.

Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).

Werwitzke S, Trick D, Sondermann P, Kamino K, Schlegelberger B, Kniesch K, Tiede A, Jacob U, Schmidt RE, Witte T.

Ann Rheum Dis. 2008 Feb;67(2):154-61. Epub 2007 Jun 8.

PMID:
17557887
8.

Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.

Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, Baleux F, Portier A, Durand-Gasselin I, Coffman RL, Galanaud P, Peuchmaur M, Emilie D.

J Immunol. 2003 Mar 15;170(6):3392-400.

10.

Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens.

Mjelle JE, Rekvig OP, Van Der Vlag J, Fenton KA.

Autoimmunity. 2011 Aug;44(5):373-83. doi: 10.3109/08916934.2010.541170. Epub 2011 Jan 19.

PMID:
21244336
12.

Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice.

Tao X, Fan F, Hoffmann V, Longo NS, Lipsky PE.

Arthritis Res Ther. 2006;8(1):R24. Epub 2006 Jan 3.

13.

Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.

Chen M, Aosai F, Norose K, Mun HS, Ishikura H, Hirose S, Piao LX, Fang H, Yano A.

Int Immunol. 2004 Jul;16(7):937-46. Epub 2004 May 17.

PMID:
15148287
14.

Soluble human CD83 ameliorates lupus in NZB/W F1 mice.

Starke C, Steinkasserer A, Voll RE, Zinser E.

Immunobiology. 2013 Nov;218(11):1411-5. doi: 10.1016/j.imbio.2013.06.002. Epub 2013 Jun 17.

PMID:
23886695
15.

Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.

Lui SL, Tsang R, Chan KW, Zhang F, Tam S, Yung S, Chan TM.

Nephrol Dial Transplant. 2008 Sep;23(9):2768-76. doi: 10.1093/ndt/gfn216. Epub 2008 Apr 29.

PMID:
18445640
16.

Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody.

Ravirajan CT, Wang Y, Matis LA, Papadaki L, Griffiths MH, Latchman DS, Isenberg DA.

Rheumatology (Oxford). 2004 Apr;43(4):442-7. Epub 2004 Jan 6. Erratum in: Rheumatology (Oxford). 2004 Apr;43(4):541.

PMID:
15024133
17.

Treatment of lupus in NZB/W F1 mice with monoclonal antibody against Fas ligand.

Nakajima A, Hirai H, Kayagaki N, Yoshino S, Hirose S, Yagita H, Okumura K.

J Autoimmun. 2000 Mar;14(2):151-7.

PMID:
10677246
18.
19.

Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice.

Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A.

J Immunol. 2003 Jun 1;170(11):5793-8.

20.

Nephritogenicity of anti-proteoglycan antibodies in experimental murine lupus nephritis.

Kashihara N, Makino H, Szekanecz Z, Waltenbaugh CR, Kanwar YS.

Lab Invest. 1992 Dec;67(6):752-60.

PMID:
1460866

Supplemental Content

Support Center